March 11, 2025 - 03:42

BOSTON & MONTREAL, March 10, 2025 -- enGene Holdings Inc., a clinical-stage company specializing in non-viral genetic medicines, has reported its financial results for the first quarter ending January 31, 2025. The company is focused on advancing innovative therapies aimed at treating various diseases through its proprietary genetic medicine platform.
In the financial report, enGene highlighted key metrics that reflect its ongoing commitment to research and development in the genetic medicine field. The company continues to invest in its pipeline of product candidates, which are designed to address unmet medical needs. The management team expressed optimism about the progress made during the quarter and reaffirmed its strategic goals moving forward.
Additionally, enGene provided insights into its operational achievements and future plans. The company remains dedicated to enhancing its capabilities and expanding its footprint in the genetic medicine landscape, aiming to deliver transformative solutions to patients worldwide.
December 17, 2025 - 01:09
Key Insights from the Year-End Jobs ReportThe latest jobs report released by the Bureau of Labor Statistics has shed light on the current state of the labor market as the year comes to a close. One of the most significant findings is the...
December 16, 2025 - 08:57
Engineer Discusses the Limitations of Vibe Coding in AI DevelopmentThe engineer behind Claude Code has shed light on the current limitations of vibe coding, particularly in the context of artificial intelligence. While vibe coding has shown promise for rapid...
December 15, 2025 - 22:01
Ford Shifts Gears: Ends F-150 Lightning Production and Ventures into Battery StorageIt looks like battery electric vehicles are out of fashion at the Blue Oval. Ford has announced the cessation of production for its popular F-150 Lightning electric truck, a move that signals a...
December 15, 2025 - 02:12
Fort Worth Welcomes New Corporate Jet Services CompanyFort Worth is making headlines with the arrival of a dedicated corporate jet services company, marking a significant boost to the local economy and the aviation sector. This development is expected...